Leptomeningeal Metastases in Hormone Refractory Prostate Cancer

Leptomeningeal metastases from the prostate are extremely rare, with few cases described in the medical literature (antemortem prevalence of less than 0.03%). Prostatic leptomeningeal metastases harbour a poor prognosis with a median survival after diagnosis of 15.7 weeks. We present the case of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Jessica Y, Ng, Justin Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997428/
https://www.ncbi.nlm.nih.gov/pubmed/29900090
http://dx.doi.org/10.7759/cureus.2470
Descripción
Sumario:Leptomeningeal metastases from the prostate are extremely rare, with few cases described in the medical literature (antemortem prevalence of less than 0.03%). Prostatic leptomeningeal metastases harbour a poor prognosis with a median survival after diagnosis of 15.7 weeks. We present the case of an 82-year-old male with a history of hormone-refractory prostate cancer who presented to the emergency department with neurological symptoms. 

Ejemplares similares